Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)
- Status
- SUSPENDED
- Phase
- PHASE1
Clinical Trials Related to Glioblastoma Multiforme
Related studies linked through entity extraction aliases.
Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- Status
- RECRUITING
- Phase
- PHASE1
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
- Status
- UNKNOWN
- Phase
- N/A
A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients
- Status
- COMPLETED
- Phase
- N/A
A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.
- Status
- RECRUITING
- Phase
- NA
131I-IPA and Concurrent XRT in Recurrent GBM
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
- Status
- UNKNOWN
- Phase
- NA
Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE3
ExAblate Blood-Brain Barrier Disruption for Glioblastoma in Patients Undergoing Standard Chemotherapy
- Status
- COMPLETED
- Phase
- NA
Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM
- Status
- TERMINATED
- Phase
- PHASE1